Insel Gruppe AG, University Hospital Bern: Hypoglycemia trials
The registry lists 12 Hypoglycemia studies with Insel Gruppe AG, University Hospital Bern as lead sponsor. 0 are open to participants now and 0 have results posted.
Early Phase 1 1Phase 4 1No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- The HypoVoice StudyCompletedNCT05569876Not applicable
- The HEADWIND Study - Part 4CompletedNCT05308095Not applicable
- The HEADWIND Study - Part 3CompletedNCT05183191Not applicable
- Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric BypassCompletedNCT05057819Phase 4
- The RADAR Study - Wearable-Based Dysglycemia Detection and Warning in DiabetesCompletedNCT04689685
- Caffeine Ingestion to Counter the Exercise-mediated Fall in Glycaemia in Type 1 DiabetesCompletedNCT04671043Not applicable
- The HEADWIND Study - Part 2CompletedNCT04569630Not applicable
- Micro Glucagon During Exercise in Type 1 DiabetesWithdrawnNCT04192019Early Phase 1
- The HEADWIND-StudyCompletedNCT04035993Not applicable
- Understanding Hypoglycaemia After Bariatric SurgeryCompletedNCT03609632Not applicable
- Fructose in Exercising Individuals With Type 1 Diabetes Using Insulin DegludecCompletedNCT03497260Not applicable
- Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 DiabetesCompletedNCT02068638Not applicable